Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122801
Filing Date
2024-11-07
Accepted
2024-11-07 07:30:24
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rapp-20240930.htm   iXBRL 10-Q 2662365
2 EX-31.1 rapp-ex31_1.htm EX-31.1 16306
3 EX-31.2 rapp-ex31_2.htm EX-31.2 16303
4 EX-32.1 rapp-ex32_1.htm EX-32.1 14212
  Complete submission text file 0000950170-24-122801.txt   8974220

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapp-20240930.xsd EX-101.SCH 1190776
69 EXTRACTED XBRL INSTANCE DOCUMENT rapp-20240930_htm.xml XML 1356516
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42121 | Film No.: 241433182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)